Turnstone Biologics Corp.
TSBX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $2,018 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $301 | $1,009 | $500 |
| Gross Profit | $0 | -$301 | $1,009 | -$500 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $171 | $4,357 | $8,160 | $14,424 |
| G&A Expenses | $5,388 | $4,807 | $3,218 | $3,944 |
| SG&A Expenses | $5,388 | $4,807 | $3,218 | $3,944 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $92 | $0 | $500 | $0 |
| Operating Expenses | $5,651 | $9,164 | $11,878 | $18,368 |
| Operating Income | -$5,559 | -$9,164 | -$11,378 | -$18,368 |
| % Margin | – | – | -563.8% | – |
| Other Income/Exp. Net | $81 | -$2,640 | -$659 | $520 |
| Pre-Tax Income | -$5,478 | -$11,804 | -$12,037 | -$17,848 |
| Tax Expense | $12 | $2 | $835 | -$816 |
| Net Income | -$5,490 | -$11,806 | -$12,872 | -$17,032 |
| % Margin | – | – | -637.9% | – |
| EPS | -0.24 | -0.51 | -0.56 | -0.74 |
| % Growth | 52.9% | 8.9% | 24.3% | – |
| EPS Diluted | -0.24 | -0.51 | -0.56 | -0.74 |
| Weighted Avg Shares Out | 23,141 | 23,138 | 23,060 | 23,038 |
| Weighted Avg Shares Out Dil | 23,141 | 23,138 | 23,060 | 23,038 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $301 | $337 | $491 |
| EBITDA | -$5,559 | -$11,503 | -$11,041 | -$17,877 |
| % Margin | – | – | -547.1% | – |